Eur Rev Med Pharmacol Sci 2016; 20 (19): 3953-3954

Editorial – PHACTR4/STAT3 axis as a possible target therapy for hepatocellular carcinoma treatment

G. Li Volti, A. Zanghì, G. Zanghì

Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. livolti@unict.it

Free PDF Download

To cite this article

G. Li Volti, A. Zanghì, G. Zanghì
Editorial – PHACTR4/STAT3 axis as a possible target therapy for hepatocellular carcinoma treatment

Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 19
Pages: 3953-3954

Keywords Related articles:

  1. PHACTR4 regulates proliferation, migration and invasion of human hepatocellular carcinoma by inhibiting IL-6/Stat3 pathway
  2. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique
  3. MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells
  4. HIFs-MiR-33a-Twsit1 axis can regulate invasiveness of hepatocellular cancer cells
  5. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma